Latest News
Why did Intel stock take another dive in April?
Via The Motley Fool · May 5, 2025
Via The Motley Fool · May 5, 2025
Via The Motley Fool · May 5, 2025
The dollar is down 8.6% since President Trump’s inauguration, almost exactly mirroring Nixon’s Smithsonian Agreement devaluation.
Via Talk Markets · May 5, 2025
Progyny stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, rising from 66 to 73.
Via Investor's Business Daily · May 5, 2025
Cotton was higher and closed near the highs of the week. Trends are turning up in this market as planting conditions remain good.
Via Talk Markets · May 5, 2025
Computer software Nebius Group stock had its Relative Strength (RS) Rating upgraded to 84 Monday, up from 77 a day earlier.
Via Investor's Business Daily · May 5, 2025
JPMorgan analyst Michael Rehaut reiterated an Underweight rating on Stanley Black & Decker (NYSE:SWK) and slashed the price target from $93 to $60 following weaker Q1 results and tariff pressures. The company cut its 2025 EPS outlook to $4.50, down from $5.25, citing a $0.75 per share tariff impact.
Via Benzinga · May 5, 2025
Binance (CRYPTO: BNB) founder Changpeng Zhao, also known as CZ, has offered his first detailed account of his prison experience, describing the mental and emotional strain, the fear he felt upon arrival and the realities of being
Via Benzinga · May 5, 2025
Via The Motley Fool · May 5, 2025
Wall Street rebounds from tariff losses, with S&P 500 recording second consecutive weekly gain. Top performers were tech giants and leveraged ETFs.
Via Benzinga · May 5, 2025
Rosenblatt analyst maintains Buy rating on Datadog, lowers price target to $150. Datadog to report Q1 results on May 6 with expected 21% revenue growth and continued investment in AI-driven applications.
Via Benzinga · May 5, 2025
Berkshire's most powerful phase still lies ahead: Here's an analysis based on this contributor's proprietary principles.
Via Benzinga · May 5, 2025
The Parkland deal is expected to result in $250 million in annual cost savings by the end of the third year and boost cash flow by 10%.
Via Stocktwits · May 5, 2025
Shares of medical device company Zimmer Biomet (NYSE:ZBH)
fell 10.2% in the afternoon session after the company reported underwhelming first quarter 2025 results as it lowered its full-year EPS guidance. A key takeaway was the weak growth. Sales were up just 1% as demand for some product lines came in weaker. While hips and trauma gear did well, others, like bone cement and surgical tools, dropped nearly 5%. Overall, this was a softer quarter.
Via StockStory · May 5, 2025
Shares of medical device company Integra LifeSciences (NASDAQ:IART)
fell 28.5% in the morning session after the company reported weak first-quarter 2025 results, which included a significant miss on full-year EPS guidance and the next quarter's revenue outlook.
Via StockStory · May 5, 2025
Shares of footwear company Skechers (NYSE:SKX)
jumped 26.2% in the pre-market session after the company announced it has agreed to be acquired by 3G Capital. 3G Capital will pay $63 per share in cash for all outstanding shares of Skechers, representing a premium of 30% to Skechers' 15-day volume-weighted average stock price. This significant premium likely signals 3G Capital's confidence in Skechers' brand strength and potential and should offer some current shareholders an immediate and attractive return on their investment.
Via StockStory · May 5, 2025
Shares of security systems manufacturer Napco (NASDAQ:NSSC) jumped 8.8% in the morning session after the company reported impressive third quarter 20225 results as sales, earnings, and EBITDA all exceeded Wall Street expectations. The company reported solid gains in service sales, which rose 11% and now make up about half of all sales. With more of these high-markup services in the mix, gross margin improved.
Via StockStory · May 5, 2025
Shares of aircraft leasing company FTAI Aviation (NASDAQ:FTAI) jumped 9.6% in the afternoon session after the stock continued its upward momentum as Wall Street analysts reaffirmed their bullish outlook.
Via StockStory · May 5, 2025
Shares of meat company Tyson Foods (NYSE:TSN)
fell 9.7% in the morning session after the company reported weak first-quarter 2025 results, which included a miss on revenue and gross margin, despite beating analysts' EBITDA expectations and EPS estimates. Sales were roughly unchanged from the prior year, held back by volume declines in pork and prepared foods, though improved pricing helped cushion the blow.
Looking ahead, they're expecting sales to stay flat or tick up slightly, with most of the growth in profits coming from chicken and prepared foods. So, while the quarter wasn't great, there were some clear wins underneath the surface.
Via StockStory · May 5, 2025
Goldman Sachs upgrades Sotera Health to Buy, citing tariff immunity, legal clarity, and exposure to Medtech innovation for future growth.
Via Benzinga · May 5, 2025
CEO William B. Horne said the year began with growth across several core business segments.
Via Stocktwits · May 5, 2025
ISM services remains above expansion level of 50 with concerns over tariffs rising.
Via Talk Markets · May 5, 2025